The phosphatase PTEN-mediated control of PI-3 kinase in Tregs cells maintains homeostasis and lineage stability

[1]  Dalya R. Soond,et al.  Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer , 2016, Nature.

[2]  H. Chi,et al.  Regulatory T cells require the phosphatase PTEN to restrain type 1 and follicular helper T-cell responses , 2015, Nature Immunology.

[3]  Dalya R. Soond,et al.  Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer , 2014, Nature.

[4]  L. Turka,et al.  Signals and pathways controlling regulatory T cells , 2014, Immunological reviews.

[5]  D. Campbell,et al.  CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets , 2014, The Journal of experimental medicine.

[6]  Jie Shen,et al.  Characterization of Two Distinct Lymphoproliferative Diseases Caused by Ectopic Expression of the Notch Ligand DLL4 on T Cells , 2013, PloS one.

[7]  Hiroshi Takayanagi,et al.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis , 2013, Nature Medicine.

[8]  J. Bluestone,et al.  Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. , 2013, Immunity.

[9]  D. Finkelstein,et al.  Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis , 2013, Nature.

[10]  Peter Vogel,et al.  mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.

[11]  L. Turka,et al.  An obligate cell-intrinsic function for CD28 in Tregs. , 2013, The Journal of clinical investigation.

[12]  Michael Q. Zhang,et al.  Novel Foxo1-dependent transcriptional programs control Treg cell function , 2012, Nature.

[13]  D. Green,et al.  Metabolic checkpoints in activated T cells , 2012, Nature Immunology.

[14]  P. Pandolfi,et al.  Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State , 2012, Cell.

[15]  H. Waldmann,et al.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. , 2012, Immunity.

[16]  Sudha Kumari,et al.  Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function , 2012, Proceedings of the National Academy of Sciences.

[17]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[18]  A. Newton,et al.  Cutting Edge: PHLPP Regulates the Development, Function, and Molecular Signaling Pathways of Regulatory T Cells , 2011, The Journal of Immunology.

[19]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[20]  Christophe Benoist,et al.  Stability of the Regulatory T Cell Lineage in Vivo , 2010, Science.

[21]  R. DePinho,et al.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells , 2010, Nature Immunology.

[22]  W. Pear,et al.  Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. , 2010, The Journal of clinical investigation.

[23]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[24]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[25]  L. Bradley.  Faculty Opinions recommendation of The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. , 2009 .

[26]  J. Sprent,et al.  In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.

[27]  Michael T. McManus,et al.  Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity , 2008, The Journal of experimental medicine.

[28]  David K. Finlay,et al.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR , 2008, Proceedings of the National Academy of Sciences.

[29]  K. Kretschmer,et al.  DNA methylation controls Foxp3 gene expression , 2008, European journal of immunology.

[30]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[31]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[32]  C. Benoist,et al.  The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.

[33]  Christophe Benoist,et al.  Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.

[34]  Y. Wan,et al.  Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.

[35]  M. Farrar,et al.  IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells1 , 2007, The Journal of Immunology.

[36]  L. Turka,et al.  PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. , 2006, The Journal of clinical investigation.

[37]  A. Rudensky,et al.  An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires , 2006, Nature Immunology.

[38]  L. A. Stephens,et al.  Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.

[39]  M. Farrar,et al.  Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[40]  Jeremy Nathans,et al.  A Noninvasive Genetic/Pharmacologic Strategy for Visualizing Cell Morphology and Clonal Relationships in the Mouse , 2003, The Journal of Neuroscience.

[41]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[42]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[43]  T. Mak,et al.  Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease , 2001, Nature Genetics.

[44]  David R. Plas,et al.  Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.

[45]  T. Sasaki,et al.  T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.

[46]  P. Pandolfi,et al.  Impaired Fas response and autoimmunity in Pten+/- mice. , 1999, Science.

[47]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[48]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[49]  S. Ward,et al.  Regulation of D‐3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens , 1992, European journal of immunology.

[50]  A. Newton,et al.  PHLPP Regulates the Development, Function and Molecular Signaling Pathways of T Regulatory Cells , 2010 .

[51]  R. Negrin,et al.  Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. , 2008, Blood.

[52]  A. Rudensky,et al.  Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells , 2003 .

[53]  Ray H. Baughman,et al.  Supporting Online Material , 2003 .